BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
4 hedge funds and large institutions have $252K invested in BiondVax Pharmaceuticals Ltd. in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
320% more capital invested
Capital invested by funds: $60K → $252K (+$192K)
33% more funds holding
Funds holding: 3 → 4 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.97K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$32 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $189K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $55K | -$1.97K | -1,483 | -7% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $5K | +$2.65K | +2,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $3K | -$32 | -24 | -2% |
|
BVXVW Hedge Fund Activity: Q4 2019 in Review
4 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q4 2019, worth a combined $252K — up 320% from $60K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BVXVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $2.65K. The largest seller was Susquehanna International Group, cutting an estimated $1.97K.
- 4 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q4 2019, up from 3 in Q3 2019.
- Funds reported $252K of BiondVax Pharmaceuticals Ltd. stock for Q4 2019, up 320% quarter-over-quarter.
- 1 fund opened new BiondVax Pharmaceuticals Ltd. positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest BiondVax Pharmaceuticals Ltd. buyer in Q4 2019 was Bank of America, an estimated $2.65K added.
- The largest BiondVax Pharmaceuticals Ltd. seller in Q4 2019 was Susquehanna International Group, an estimated $1.97K sold.
Based on aggregated 13F filings for Q4 2019.